Molecular Pain Research

Molecular Pain Research

Chronic pain is a major health problem affecting about 20 percent of the Swedish population, resulting in markedly reduced quality of life for the individual. Pain is also a substantial socio-economical problem and the cost for chronic pain in Sweden has been estimated to a staggering SEK 87,5 billion in medical treatment, loss of productivity and disability (SBU, Swedish Council on Health Technology Assessment, 2006). Unfortunately, there are currently few available effective treatments for chronic pain conditions. Hence, we believe that it is critical to increase our understanding for how chronic pain is regulated in order to identify new treatment strategies and novel drug targets for pain relief.

We are currently studying pain in pathological conditions, such as rheumatoid arthritis (RA), osteoarthritis (OA), fibromyalgia and low back pain, and we are working together with both preclinical and clinical researchers with a mission to increase our ability to study pain from a translational aspect from bench to bedside.


Group leader

Camilla Svensson


Job title






Fibromyalgia, Osteoarthritis, Rheumatic diseases, Rheumatoid arthritis